ZymoGenetics has hired Stephen W. Zaruby as corporate president and general manager of a new division.
Oncolytics Biotech appointed Matt Coffey as chief operating officer of the company. Coffey was formerly chief scientific officer of Oncolytics.
PDL BioPharma has appointed Christine Larson as its vice president and chief financial officer.
SV Life Sciences has named Paul LaViolette as a new venture partner.
Ronald J. Shebuski, Ph.D. will join Symmetrix Pharmaceuticals, LLC as Chief Scientific Officer.
Praxis has added Megan Sturm as business development manager to oversee activities for Praxis' Northeast U.S. and Southern California territories.
BioCryst Pharmaceuticals announced that Stanley C. Erck has been elected to the board of directors.
AspenBio Pharma has appointed John H. Landon as an independent member of its board of directors.
Applied NeuroSolutions renewed its consulting agreement with Peter Davies, Ph.D., the company's founding scientist.
Repros Therapeutics has elected Mark Lappe of Efficacy Capital as its chairman.
Achillion has named Dennis C. Liotta, Ph.D. to its board. Dr. Liotta will fill the vacancy created by the departure of Jean-Francois Formela, M.D.
Luc Montagnier, co-winner of the 2008 Nobel Prize for Medicine and the co-discoverer of the HIV virus, has joined Viral Genetics as an adviser.
Neogenix Oncology has named Theodore C. Sorensen as vice-chairman.